glp-1 receptor antagonist GLP-1R 1 | GLP-1R Antagonist GLP-1 (Glucagon-Like Peptide-1) Is Physiologically

The Journal of Pediatrics 236 , 137-147.e13 (2021)

Yun Weisholtz, MD-PhD Dr

Biology of incretins: GLP-1 and GIP

Compounded GLP-1s have not been evaluated by the FDA, but side effects are expected to be similar to other GLP-1-based medications reviewed by the FDA, which have the following side effects: nausea, diarrhea, vomiting, constipation, abdominal (stomach) pain, headache, fatigue, dyspepsia (indigestion), dizziness, abdominal distension, eructation (belching), hypoglycemia (low blood sugar), flatulence (gas buildup), gastroenteritis (an intestinal infection), and gastroesophageal reflux disease (a type of digestive disorder)